Omega Healthcare Investors, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Omega is a healthcare-focused REIT investing primarily in skilled nursing facilities, assisted living facilities, specialty facilities, medical office buildings, mortgage loans and operator-related investments in the U.S. and U.K. The filing covers the three and nine months ended September 30, 2022; financial statements are unaudited. The portfolio included 941 healthcare facilities operated by 65 third-party operators across 42 states and the U.K.
Key Financial Metrics
| Metric | Q3 2022 | Q3 2021 | Change |
|---|---|---|---|
| Total revenue | $239.4 million | $281.7 million | Down 15.0% |
| Net income | $105.1 million | $142.8 million | Down 26.5% |
| Net income available to common stockholders | $102.3 million | $138.9 million | Down 26.4% |
| Basic EPS | $0.44 | $0.58 | Down $0.14 |
| Nareit FFO | $159.1 million | $180.7 million | Down 11.9% |
| Net cash from operating activities | $472.0 million for nine months | Down from $565.6 million |
For the nine months ended September 30, 2022, revenue was $733.4 million versus $812.9 million in the prior-year period, while net income available to common stockholders was $381.3 million versus $383.4 million. Basic EPS was $1.61 versus $1.62. Approximate GAAP net margin was 43.9% in Q3 2022 versus 50.7% in Q3 2021; the comparison was materially affected by gains on asset sales and noncash items.
Q3 rental income was $207.6 million, down $39.6 million, primarily due to operator payment shortfalls, cash-basis accounting, facility sales and restructurings. Mortgage interest income declined to $17.2 million from $23.0 million, while other investment income increased to $14.1 million from $10.8 million.
Balance Sheet, Debt and Liquidity
- Total assets were $9.48 billion at September 30, 2022, compared with $9.64 billion at December 31, 2021.
- Total debt was approximately $5.28 billion, representing approximately 57.8% of total capitalization. The weighted-average interest rate was 4.1%, and 98% of outstanding principal had fixed interest payments.
- Senior notes and other unsecured borrowings were $4.90 billion; secured borrowings were $368.4 million; and borrowings under the revolving credit facility were $17.9 million.
- Cash, cash equivalents and restricted cash totaled $138.2 million, up from $24.4 million at December 31, 2021. Cash availability also included unused capacity under the $1.45 billion revolving credit facility and approximately $929.9 million of remaining capacity under the 2021 ATM program.
- Management stated that available sources are expected to fund dividends, debt service, investments, loan advances and recurring expenses for at least the next twelve months.
- The company was in compliance with applicable debt covenants at September 30, 2022. Credit ratings were Baa3 from Moody’s and BBB- from S&P Global and Fitch.
Material Changes Versus the Prior Comparable Period
- Operating cash flow declined by $93.6 million for the nine-month period, primarily because of lower rental and mortgage revenue.
- Investing activities generated $272.4 million of cash in 2022 versus using $452.2 million in 2021, reflecting greater property-sale proceeds, mortgage collections and lower acquisitions, partly offset by increased advances under other investment loans.
- Omega sold four facilities for $51.4 million of net proceeds in Q3 and 44 facilities for $438.3 million during the nine months, recognizing gains of $40.9 million and $179.7 million, respectively.
- Omega acquired $28.2 million of real estate in Q3 and $136.7 million year to date, compared with significantly higher acquisition activity in the prior-year period.
- Five operators were placed on a cash basis during the first nine months. Seventeen operators were on a cash basis at September 30, representing 15.3% of revenue excluding write-offs.
- Straight-line rent and lease-inducement write-offs were $13.2 million in Q3 and $23.6 million year to date. Operators also deferred $25.4 million of contractual rent and interest year to date, while $9.4 million of collateral was applied to contractual obligations.
- The company repurchased 5.2 million shares for $142.3 million during the first nine months, but made no repurchases in Q3. Quarterly dividends remained $0.67 per share.
Guidance, Outlook, Risks and Unusual Items
- No formal earnings or FFO guidance was provided in the filing.
- Management expects near-term uncertainty to persist because of staffing shortages, elevated labor costs, reduced occupancy, inflation, reimbursement uncertainty and the gradual reduction of pandemic-related government support.
- Agemo remained on a cash basis and paid no contractual rent or interest during the nine months. Omega was negotiating a restructuring; 19 Agemo facilities were sold in Q4 2022 for aggregate gross proceeds of $315.8 million.
- Guardian resumed contractual payments after Q1 2022, but its lease and mortgage were restructured. Combined annual rent and mortgage interest was reduced to $24.0 million beginning July 1, 2022, and $18.0 million of deferred rent and interest was subject to later repayment conditions.
- Real estate impairments were $10.0 million in Q3 and $21.2 million year to date. The allowance for credit losses was $124.1 million at September 30, 2022.
- Operator concentration and credit risk remain material. Maplewood and LaVie each represented more than 10% of total investments; LaVie generated approximately 11.5% of Q3 revenue and Maplewood approximately 9.3%.
- The company recorded a $31.0 million legal reserve for a securities class action, offset by a receivable because management expects insurance proceeds; therefore, there was no net income statement impact. A separate $3.0 million legal reserve was recorded in Q2 regarding a Department of Justice investigation related to Lakeway Hospital.
- Remaining commitments totaled approximately $288.1 million, including construction and capital commitments and other investment loan commitments. Management also disclosed approximately $3.9 million of maximum funding exposure under indemnification agreements.
- Key external risks include COVID-19 effects, healthcare regulation, Medicare and Medicaid reimbursement changes, the full 2% Medicare sequestration effective July 1, 2022, inflation, interest rates, operator bankruptcies and the company’s ability to sell or re-lease underperforming assets.
Most Important Facts for Investors to Verify
- Whether the 17 cash-basis operators, representing 15.3% of adjusted revenue, return to contractual payment status or require further concessions.
- The ultimate outcome and insurance recovery related to the securities class action and the Lakeway DOJ investigation.
- Progress and economics of Agemo, Guardian and other operator restructurings, including subsequent asset-sale proceeds and any additional impairments.
- Debt maturities beginning in 2023, refinancing costs, covenant headroom and the effect of changing interest rates despite the high fixed-rate debt mix.
- Whether occupancy, staffing, labor costs and government reimbursement rates improve sufficiently to support operator liquidity and rent payments.
- The sustainability of the $0.67 quarterly dividend relative to operating cash flow, FFO, required debt service and committed capital investments.